Medifirst Solutions Inc (OTCMKTS:MFST) Sales Look Set To Roll In Near Term

Medifirst Solutions Inc (OTCMKTS:MFST) just announced the appointment of a new Advisory Board member, and with the announcement coming less than 24 hours after a sales strategy update, the company is up more than 24%. Both announcements are positive developments, and we think two quotes from the latest board addition announcement highlight why.Here's the first, from Bill White, the latest Advisory Board HR add:

"The Time Machine Lasers present a unique product with explosive growth potential. I look forward to assisting the company in monetizing its incredible technology."

Here's the second, from Medifirst's CEO Bruce J. Schoengood:

"(Bill) brings decades of management experience that will be invaluable to Medifirst as it now enters its sales, marketing and distribution phase."

Bringing these two quotes together, we've got two industry veterans saying this: Medifirst has very valuable technology, and it's about to start executing on a strategy to cash in on that value.Of course, if there were two individuals most likely to make this suggestion, it’s the CEO of the company that developed the product and the guy that just came on board to ensure its success in the commercialization phase. With this in mind, we're asking the question, is there any credence to the suggestion?Let's take a look.The technology in question is called the Time Machine Laser, more specifically referred to as the TTML-8102000 Laser Thermal Therapeutic Device. It's designed to improve scar incision healing, as well as target things like joint pain, arthritis complications and a host of other tissue/muscle rooted issues. It's handheld, and its accuracy, purportedly, allows for immediate results with no redness, swelling or down-time. The FDA cleared a Premarket Notification 510(k) submission for the laser system back in July 2016, and Medifirst has spent the last few months laying the framework for a sales push.As a quick housekeeping note, the company is marketing the Time Machine Laser through its wholly owned subsidiary, Medical Lasers Manufacturer, or MLM.Which brings us to the latest announcements.The just mentioned framework looks to be finally in place, MLM is ready to start pushing the Time Machine both domestically and abroad. The company has fitted itself out with a New Jersey based office, complete with sales force, and is in the process of brushing up on some FDA mandated internal controls and compliance procedures, which if last month's update is to be relied upon, should have completed at the end of last week. It's got 50 units ready to go, worth a wholesale $500,000, and a sales director is in the process of setting up shop in Dubai, from where said director will navigate the middle east markets. This location just achieved its first major development, which the company announced as part of its latest sales update, reporting that it has been asked to bring its medical staff to Morocco and Dubai to demonstrate its laser technology as part of finalizing its first international sales orders.The two latest updates of this nature have both stated that sales revenue should start to roll in during the first quarter of 2017, meaning we should see revenues from both the mid east market and the US domestic market start to flow, and with a high ticket item such as the Time Machine Laser, it's not going to take too many closed sales before top line outweighs current market cap.Cash at June 30 came in at just shy of $200K, which won’t fully fund a pan-global marketing push, but it has likely served to foot the bill for this first wave of strategy execution. This, of course, means we are going to see some dilution near term, but as the sales roll on, this dilution should quickly mitigate.Bottom line here is that MediFirst has carried its product through a long and expensive development phase, with the goal of reaching exactly this situation. Now is an inflection point, where strategy shifts from successfully navigating development to successfully executing commercialization.We will be updating our subscribers as soon as we know more. For the latest updates on MFST, sign up below!Disclosure: We have no position in MFST and have not been compensated for this article.